(Q36457881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Communication and informed consent in phase 1 trials: a review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

phase I clinical trial

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anna Clare Cox

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

V A Jenkins

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

28 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

303-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations

19 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-005-0916-2

Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients

21 January 2018

1 reference

12 December 2020

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

1 reference

12 December 2020

Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences.

1 reference

12 December 2020

Ethics of phase 1 oncology studies: reexamining the arguments and data

1 reference

12 December 2020

Descriptions of benefits and risks in consent forms for phase 1 oncology trials

1 reference

12 December 2020

Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.

1 reference

12 December 2020

Impact of quality of life on patient expectations regarding phase I clinical trials.

1 reference

12 December 2020

Proposing phase I studies: patients', relatives', nurses' and specialists' perceptions

1 reference

12 December 2020

The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial

1 reference

12 December 2020

Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme

1 reference

12 December 2020

Quality of informed consent in cancer clinical trials: a cross-sectional survey

1 reference

12 December 2020

Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception

1 reference

12 December 2020

Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.

1 reference

12 December 2020

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

12 December 2020

Expectations and experiences of patients with cancer participating in phase I clinical trials

1 reference

12 December 2020

Physician-patient communication in phase I cancer trials

1 reference

12 December 2020

When the treatment goal is not cure: are cancer patients equipped to make informed decisions?

1 reference

12 December 2020

Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

1 reference

12 December 2020

The impact of disease severity on the informed consent process in clinical research.

1 reference

12 December 2020

Teaching senior nurses how to teach communication skills in oncology

1 reference

12 December 2020

Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials

1 reference

12 December 2020

Uncertain benefit: investigators' views and communications in early phase gene transfer trials.

1 reference

12 December 2020

Phase I trials in cancer patients: participants' perceptions

1 reference

12 December 2020

Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial

1 reference

12 December 2020

Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials

1 reference

12 December 2020

Interventions to improve research participants' understanding in informed consent for research: a systematic review

1 reference

12 December 2020

Factors that influence a patient's decision to participate in a phase I cancer clinical trial.

1 reference

12 December 2020

10.1007/S00520-005-0916-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633840%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference